Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2006Annals of the New York Academy of Sciences

Bone Destruction in Multiple Myeloma

View Full Paper
Ask AI
Bookmark
Share

Authors

TMToshio MatsumotoBrazilian Society of SpeechMAMasahiro AbeEhime Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Matsumoto et al. (2006) studied this question.

synapsesocial.com/papers/6a5dc96ebcb839ae37c5b724https://doi.org/10.1196/annals.1346.035
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cell Adhesion Mediated Drug Resistance (CAM-DR): Role of Integrins and Resistance to Apoptosis in Human Myeloma Cell Lines1999 · 873 citations
  2. 2Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma2000 · 396 citations
  3. 3Multiple Myeloma1997 · 396 citations
  4. 4Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.1998 · 438 citations
  5. 5Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion2004 · 318 citations